NCT02268578

Brief Summary

Memory difficulty ranks among the most common complaints for patients with temporal lobe epilepsy. While these cognitive problems may affect quality of life more than seizure frequency, no effective therapy exists. Transcranial Direct Current Stimulation (tDCS) is a method of safe, noninvasive, and painless brain stimulation delivering low intensity direct current through scalp electrodes to modulate brain activity. Several recently published studies demonstrate the enhancement of working memory and mood with stimulation of the frontal region of the brain. Furthermore, tDCS has never been reported to have induced a seizure. The aim of our study is to determine whether real tDCS can improve memory function and mood. The investigators are enrolling patients with well-controlled temporal lobe epilepsy who have not undergone brain surgery.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Nov 2012

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
1.9 years until next milestone

First Submitted

Initial submission to the registry

October 2, 2014

Completed
18 days until next milestone

First Posted

Study publicly available on registry

October 20, 2014

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

April 15, 2016

Status Verified

April 1, 2016

Enrollment Period

3 years

First QC Date

October 2, 2014

Last Update Submit

April 13, 2016

Conditions

Keywords

Transcranial Direct Current StimulationTDCSMemory DysfunctionDepression

Outcome Measures

Primary Outcomes (1)

  • Change in EEG Power

    Visits 1, 5, 6 & 7 over 5 weeks

Secondary Outcomes (1)

  • Cognitive Tests

    Visits 1, 5, 6 & 7 over 5 weeks

Study Arms (2)

Transcranial Direct Current Stimulation

ACTIVE COMPARATOR

Subjects will receive a total of 5 sessions on consecutive days. During each session, 2 mA of tDCS will be applied for 20 minutes over the left DLPFC (active or sham). The electrodes will have the size of 35cm2 each. Direct current will be transferred by a saline-soaked pair of surface sponge electrodes and delivered b y a specially developed, battery driven, constant current stimulator with a maximum output of 2mA.

Device: Transcranial Direct Current Stimulation

Sham TDCS

SHAM COMPARATOR

For sham-controlled tDCS subjects, the same montage will be used; however current will be applied for only 30 seconds - this is a reliable method of sham stimulation as sensations arising from tDCS treatment occur only at the beginning of application as also demonstrated by a randomized study (Gandiga et al. 2006).

Procedure: Sham Transcranial Direct Current Stimulation

Interventions

2mA tDCS

Transcranial Direct Current Stimulation

Transcranial Direct Current Stimulation is administered but at 0mA

Sham TDCS

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age between 18-70 years
  • diagnosis of temporal lobe epilepsy, with seizure focus defined by seizure semiology, EEG, MRI Brain, PET and/or ictal and interictal SPECT.
  • Must have a stable seizure frequency in the two (2) months prior to enrollment, as verified by the patient's seizure log and/or clinic notes and without recent antiepileptic medication changes.
  • Must score above 22/30 on the Montreal Cognitive Assessment (MoCA).
  • Must be able to provide informed consent.

You may not qualify if:

  • Patient has a progressive or unstable neurological or systemic disease
  • Patient has an ictal focus over the F3 or F4 (DLPFC) field
  • Patient has a history of severe depression, as determined by a screen inventory test such as the Beck Depression Inventory or a psychiatrist
  • Patient has a history of severe traumatic brain injury or prior brain surgery with skull defect
  • Contraindictations to tDCS, including metal in the head or implanted brain medical devices
  • Pregnancy
  • Any implanted electrical medical device, including pacers and implanted cardiac defibrillators
  • History of schizophrenia, schizoaffective disorder, other psychosis, rapid-cycling bipolar illness, alcohol/drug abuse within the past year
  • History of dementia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neurology

New York, New York, 11106, United States

Location

MeSH Terms

Conditions

EpilepsyDepression

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Anli Liu, MD

    NYU Langone Health

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 2, 2014

First Posted

October 20, 2014

Study Start

November 1, 2012

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

April 15, 2016

Record last verified: 2016-04

Locations